Global Equine Pharmaceuticals and Supplements Market Growth 2022-2028

  • receipt Report ID : 322797
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 144
  • list Pharmaceuticals and Healthcare
Buy @ $3660

As the global economy mends, the 2021 growth of Equine Pharmaceuticals and Supplements will have significant change from previous year. According to our latest study, the global Equine Pharmaceuticals and Supplements market size is USD million in 2022 from USD 1123 million in 2021, with a change of % between 2021 and 2022. The global Equine Pharmaceuticals and Supplements market size will reach USD 1545.6 million in 2028, growing at a CAGR of 4.7% over the analysis period.

The United States Equine Pharmaceuticals and Supplements market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Equine Pharmaceuticals and Supplements market, reaching US$ million by the year 2028. As for the Europe Equine Pharmaceuticals and Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Equine Pharmaceuticals and Supplements players cover Boehringer Ingelheim, Merck Animal Health, Zoetis, and Bayer Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Pharmaceuticals

Supplements

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Thoroughbred Horse

Other Types of Horses

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Equine Pharmaceuticals and Supplements by Country/Region, 2017, 2022 & 2028

2.2 Equine Pharmaceuticals and Supplements Segment by Type

2.2.1 Pharmaceuticals

2.2.2 Supplements

2.3 Equine Pharmaceuticals and Supplements Sales by Type

2.3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2017-2022)

2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2017-2022)

2.4 Equine Pharmaceuticals and Supplements Segment by Application

2.4.1 Thoroughbred Horse

2.4.2 Other Types of Horses

2.5 Equine Pharmaceuticals and Supplements Sales by Application

2.5.1 Global Equine Pharmaceuticals and Supplements Sale Market Share by Application (2017-2022)

2.5.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2017-2022)

2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Application (2017-2022)

3 Global Equine Pharmaceuticals and Supplements by Company

3.1 Global Equine Pharmaceuticals and Supplements Breakdown Data by Company

3.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Company (2020-2022)

3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2022)

3.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Company (2020-2022)

3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2022)

3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2022)

3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company

3.4 Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Equine Pharmaceuticals and Supplements Product Location Distribution

3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Equine Pharmaceuticals and Supplements by Geographic Region

4.1 World Historic Equine Pharmaceuticals and Supplements Market Size by Geographic Region (2017-2022)

4.1.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Geographic Region

4.2 World Historic Equine Pharmaceuticals and Supplements Market Size by Country/Region (2017-2022)

4.2.1 Global Equine Pharmaceuticals and Supplements Annual Sales by Country/Region (2017-2022)

4.2.2 Global Equine Pharmaceuticals and Supplements Annual Revenue by Country/Region

4.3 Americas Equine Pharmaceuticals and Supplements Sales Growth

4.4 APAC Equine Pharmaceuticals and Supplements Sales Growth

4.5 Europe Equine Pharmaceuticals and Supplements Sales Growth

4.6 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Growth

5 Americas

5.1 Americas Equine Pharmaceuticals and Supplements Sales by Country

5.1.1 Americas Equine Pharmaceuticals and Supplements Sales by Country (2017-2022)

5.1.2 Americas Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022)

5.2 Americas Equine Pharmaceuticals and Supplements Sales by Type

5.3 Americas Equine Pharmaceuticals and Supplements Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Equine Pharmaceuticals and Supplements Sales by Region

6.1.1 APAC Equine Pharmaceuticals and Supplements Sales by Region (2017-2022)

6.1.2 APAC Equine Pharmaceuticals and Supplements Revenue by Region (2017-2022)

6.2 APAC Equine Pharmaceuticals and Supplements Sales by Type

6.3 APAC Equine Pharmaceuticals and Supplements Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Equine Pharmaceuticals and Supplements by Country

7.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2017-2022)

7.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022)

7.2 Europe Equine Pharmaceuticals and Supplements Sales by Type

7.3 Europe Equine Pharmaceuticals and Supplements Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Country

8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2017-2022)

8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022)

8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type

8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements

10.3 Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements

10.4 Industry Chain Structure of Equine Pharmaceuticals and Supplements

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Equine Pharmaceuticals and Supplements Distributors

11.3 Equine Pharmaceuticals and Supplements Customer

12 World Forecast Review for Equine Pharmaceuticals and Supplements by Geographic Region

12.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region

12.1.1 Global Equine Pharmaceuticals and Supplements Forecast by Region (2023-2028)

12.1.2 Global Equine Pharmaceuticals and Supplements Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Equine Pharmaceuticals and Supplements Forecast by Type

12.7 Global Equine Pharmaceuticals and Supplements Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offered

13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Merck Animal Health

13.2.1 Merck Animal Health Company Information

13.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Offered

13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Animal Health Main Business Overview

13.2.5 Merck Animal Health Latest Developments

13.3 Zoetis

13.3.1 Zoetis Company Information

13.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Offered

13.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zoetis Main Business Overview

13.3.5 Zoetis Latest Developments

13.4 Bayer Animal Health

13.4.1 Bayer Animal Health Company Information

13.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offered

13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Animal Health Main Business Overview

13.4.5 Bayer Animal Health Latest Developments

13.5 Elanco Animal Health

13.5.1 Elanco Animal Health Company Information

13.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offered

13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elanco Animal Health Main Business Overview

13.5.5 Elanco Animal Health Latest Developments

13.6 Dechra Veterinary Products

13.6.1 Dechra Veterinary Products Company Information

13.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offered

13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dechra Veterinary Products Main Business Overview

13.6.5 Dechra Veterinary Products Latest Developments

13.7 CEVA

13.7.1 CEVA Company Information

13.7.2 CEVA Equine Pharmaceuticals and Supplements Product Offered

13.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 CEVA Main Business Overview

13.7.5 CEVA Latest Developments

13.8 Virbac

13.8.1 Virbac Company Information

13.8.2 Virbac Equine Pharmaceuticals and Supplements Product Offered

13.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Virbac Main Business Overview

13.8.5 Virbac Latest Developments

13.9 Norbrook Equine

13.9.1 Norbrook Equine Company Information

13.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Offered

13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Norbrook Equine Main Business Overview

13.9.5 Norbrook Equine Latest Developments

13.10 Kyoritsu Seiyaku

13.10.1 Kyoritsu Seiyaku Company Information

13.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offered

13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Kyoritsu Seiyaku Main Business Overview

13.10.5 Kyoritsu Seiyaku Latest Developments

13.11 Vetoquinol

13.11.1 Vetoquinol Company Information

13.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Offered

13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Vetoquinol Main Business Overview

13.11.5 Vetoquinol Latest Developments

13.12 Protexin Healthcare

13.12.1 Protexin Healthcare Company Information

13.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offered

13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Protexin Healthcare Main Business Overview

13.12.5 Protexin Healthcare Latest Developments

13.13 Audevard

13.13.1 Audevard Company Information

13.13.2 Audevard Equine Pharmaceuticals and Supplements Product Offered

13.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Audevard Main Business Overview

13.13.5 Audevard Latest Developments

13.14 Ouro Fino Saude

13.14.1 Ouro Fino Saude Company Information

13.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offered

13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ouro Fino Saude Main Business Overview

13.14.5 Ouro Fino Saude Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Equine Pharmaceuticals and Supplements Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pharmaceuticals

Table 4. Major Players of Supplements

Table 5. Global Equine Pharmaceuticals and Supplements Sales by Type (2017-2022) & (K Units)

Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

Table 7. Global Equine Pharmaceuticals and Supplements Revenue by Type (2017-2022) & ($ million)

Table 8. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2017-2022)

Table 9. Global Equine Pharmaceuticals and Supplements Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Equine Pharmaceuticals and Supplements Sales by Application (2017-2022) & (K Units)

Table 11. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Table 12. Global Equine Pharmaceuticals and Supplements Revenue by Application (2017-2022)

Table 13. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2017-2022)

Table 14. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Equine Pharmaceuticals and Supplements Sales by Company (2020-2022) & (K Units)

Table 16. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2020-2022)

Table 17. Global Equine Pharmaceuticals and Supplements Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2020-2022)

Table 19. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Equine Pharmaceuticals and Supplements Producing Area Distribution and Sales Area

Table 21. Players Equine Pharmaceuticals and Supplements Products Offered

Table 22. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Equine Pharmaceuticals and Supplements Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Equine Pharmaceuticals and Supplements Sales Market Share Geographic Region (2017-2022)

Table 27. Global Equine Pharmaceuticals and Supplements Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Equine Pharmaceuticals and Supplements Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Equine Pharmaceuticals and Supplements Sales Market Share by Country/Region (2017-2022)

Table 31. Global Equine Pharmaceuticals and Supplements Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Equine Pharmaceuticals and Supplements Sales by Country (2017-2022) & (K Units)

Table 34. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country (2017-2022)

Table 35. Americas Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2017-2022)

Table 37. Americas Equine Pharmaceuticals and Supplements Sales by Type (2017-2022) & (K Units)

Table 38. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

Table 39. Americas Equine Pharmaceuticals and Supplements Sales by Application (2017-2022) & (K Units)

Table 40. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Table 41. APAC Equine Pharmaceuticals and Supplements Sales by Region (2017-2022) & (K Units)

Table 42. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region (2017-2022)

Table 43. APAC Equine Pharmaceuticals and Supplements Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2017-2022)

Table 45. APAC Equine Pharmaceuticals and Supplements Sales by Type (2017-2022) & (K Units)

Table 46. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

Table 47. APAC Equine Pharmaceuticals and Supplements Sales by Application (2017-2022) & (K Units)

Table 48. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Table 49. Europe Equine Pharmaceuticals and Supplements Sales by Country (2017-2022) & (K Units)

Table 50. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2017-2022)

Table 51. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2017-2022)

Table 53. Europe Equine Pharmaceuticals and Supplements Sales by Type (2017-2022) & (K Units)

Table 54. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

Table 55. Europe Equine Pharmaceuticals and Supplements Sales by Application (2017-2022) & (K Units)

Table 56. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Equine Pharmaceuticals and Supplements

Table 66. Key Market Challenges & Risks of Equine Pharmaceuticals and Supplements

Table 67. Key Industry Trends of Equine Pharmaceuticals and Supplements

Table 68. Equine Pharmaceuticals and Supplements Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Equine Pharmaceuticals and Supplements Distributors List

Table 71. Equine Pharmaceuticals and Supplements Customer List

Table 72. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Equine Pharmaceuticals and Supplements Sales Market Forecast by Region

Table 74. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Equine Pharmaceuticals and Supplements Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Equine Pharmaceuticals and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Equine Pharmaceuticals and Supplements Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Equine Pharmaceuticals and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Application (2023-2028)

Table 92. Boehringer Ingelheim Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 93. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Offered

Table 94. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Boehringer Ingelheim Main Business

Table 96. Boehringer Ingelheim Latest Developments

Table 97. Merck Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Animal Health Equine Pharmaceuticals and Supplements Product Offered

Table 99. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Merck Animal Health Main Business

Table 101. Merck Animal Health Latest Developments

Table 102. Zoetis Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 103. Zoetis Equine Pharmaceuticals and Supplements Product Offered

Table 104. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Zoetis Main Business

Table 106. Zoetis Latest Developments

Table 107. Bayer Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 108. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Offered

Table 109. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Bayer Animal Health Main Business

Table 111. Bayer Animal Health Latest Developments

Table 112. Elanco Animal Health Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 113. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Offered

Table 114. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Elanco Animal Health Main Business

Table 116. Elanco Animal Health Latest Developments

Table 117. Dechra Veterinary Products Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 118. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Offered

Table 119. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Dechra Veterinary Products Main Business

Table 121. Dechra Veterinary Products Latest Developments

Table 122. CEVA Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 123. CEVA Equine Pharmaceuticals and Supplements Product Offered

Table 124. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. CEVA Main Business

Table 126. CEVA Latest Developments

Table 127. Virbac Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 128. Virbac Equine Pharmaceuticals and Supplements Product Offered

Table 129. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Virbac Main Business

Table 131. Virbac Latest Developments

Table 132. Norbrook Equine Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 133. Norbrook Equine Equine Pharmaceuticals and Supplements Product Offered

Table 134. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Norbrook Equine Main Business

Table 136. Norbrook Equine Latest Developments

Table 137. Kyoritsu Seiyaku Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 138. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Offered

Table 139. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Kyoritsu Seiyaku Main Business

Table 141. Kyoritsu Seiyaku Latest Developments

Table 142. Vetoquinol Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 143. Vetoquinol Equine Pharmaceuticals and Supplements Product Offered

Table 144. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Vetoquinol Main Business

Table 146. Vetoquinol Latest Developments

Table 147. Protexin Healthcare Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 148. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Offered

Table 149. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Protexin Healthcare Main Business

Table 151. Protexin Healthcare Latest Developments

Table 152. Audevard Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 153. Audevard Equine Pharmaceuticals and Supplements Product Offered

Table 154. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Audevard Main Business

Table 156. Audevard Latest Developments

Table 157. Ouro Fino Saude Basic Information, Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 158. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Offered

Table 159. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Ouro Fino Saude Main Business

Table 161. Ouro Fino Saude Latest Developments

List of Figures

Figure 1. Picture of Equine Pharmaceuticals and Supplements

Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Equine Pharmaceuticals and Supplements Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Equine Pharmaceuticals and Supplements Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Equine Pharmaceuticals and Supplements Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pharmaceuticals

Figure 10. Product Picture of Supplements

Figure 11. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2021

Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2017-2022)

Figure 13. Equine Pharmaceuticals and Supplements Consumed in Thoroughbred Horse

Figure 14. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2017-2022) & (K Units)

Figure 15. Equine Pharmaceuticals and Supplements Consumed in Other Types of Horses

Figure 16. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2017-2022) & (K Units)

Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2017-2022)

Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application in 2021

Figure 19. Equine Pharmaceuticals and Supplements Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2021

Figure 21. Global Equine Pharmaceuticals and Supplements Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Geographic Region in 2021

Figure 23. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2017-2022)

Figure 24. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Country/Region in 2021

Figure 25. Americas Equine Pharmaceuticals and Supplements Sales 2017-2022 (K Units)

Figure 26. Americas Equine Pharmaceuticals and Supplements Revenue 2017-2022 ($ Millions)

Figure 27. APAC Equine Pharmaceuticals and Supplements Sales 2017-2022 (K Units)

Figure 28. APAC Equine Pharmaceuticals and Supplements Revenue 2017-2022 ($ Millions)

Figure 29. Europe Equine Pharmaceuticals and Supplements Sales 2017-2022 (K Units)

Figure 30. Europe Equine Pharmaceuticals and Supplements Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Equine Pharmaceuticals and Supplements Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue 2017-2022 ($ Millions)

Figure 33. Americas Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2021

Figure 34. Americas Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2021

Figure 35. United States Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2021

Figure 40. APAC Equine Pharmaceuticals and Supplements Revenue Market Share by Regions in 2021

Figure 41. China Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2021

Figure 48. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2021

Figure 49. Germany Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country in 2021

Figure 56. Egypt Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Equine Pharmaceuticals and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements in 2021

Figure 62. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements

Figure 63. Industry Chain Structure of Equine Pharmaceuticals and Supplements

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles